As of April 1, 2024
|
Representative Director President & CEO |
Kenshi Terada |
Management of Development & Commercialization DIV. |
|
|
Director Lead Executive Officer |
Atsuo Konishi |
Management of Production/Plant/Process Technology DIV. General Manager,Engineering & Technology DIV. |
|
|
Takeshi Kimura |
Management of Chemicals DIV. & Chemical Specialties DIV. Management of Health Care DIV. Management of Promotion of Globalization General Manager,Chemical Specialties DIV. General Manager,Health Care DIV. |
||
|
Director |
（Outside） |
Bun'yu Futamura |
|
|
（Outside） |
Hakaru Hyakushima |
||
|
（Outside） |
Okiko Miyata |
||
|
Auditor |
Yasushi Segawa |
||
|
（Outside） |
Shigetsugu Fujiyabu |
||
|
（Outside） |
Shinji Mori |
||
|
Executive Officer |
Kenichi Katsuma |
General Manager,Chemicals DIV. |
|
|
Toru Imamura |
General Manager,Administration DIV. |
||